ASH 2018 Prof dr. Frank Leebeek

Prof dr. Frank Leebeek, internist-hematoloog, Erasmus MC, Rotterdam

 

Reduction in Annualized Bleeding and Factor IX Consumption up to 2.5 Years in Adults with Severe or Moderate-Severe Hemophilia B Treated with AMT-060 (AAV5-hFIX) Gene Therapy

 

https://ash.confex.com/ash/2018/webprogram/Paper109995.html

 

0119HEM1092342
×

Ask Speakers

×

Medical Information Request